Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Covid-19 crawled date : 2021 - 05 - 27 save search
$727.4 Million Worldwide Sterility Indicators Industry to 2027 - Impact of COVID-19 on the Market
Published: 2021-05-27 (Crawled : 22:00) - prnewswire.com
STE | $202.8 -1.55% 0.0% 490K
|
Health Technology
|
| O: 0.44%
H: 0.83%
C: -0.45%
MMM | $92.02 -1.05% 0.17% 2.7M
|
Producer Manufacturing
|
| O: 0.31%
H: 0.25%
C: -0.41%
covid indicator covid-19
Udpated TDI COVID-19 Mask Policy
Published: 2021-05-27 (Crawled : 20:00) - taylordevices.com
TAYD A | $53.01 -1.43% -1.32% 18K
|
Producer Manufacturing
|
| O: 0.0%
H: 0.0%
C: 0.0%
covid mask covid-19
$1.8 Billion Worldwide Endoscope Reprocessing Industry to 2027 - Impact Analysis of COVID-19
Published: 2021-05-27 (Crawled : 20:00) - prnewswire.com
JNJ | News | $148.53 -0.69% 0.11% 67K
|
Health Technology
|
| O: 0.42%
H: 0.88%
C: -0.16%
ECL | News | $220.78 0.51% 0.0% 56
|
Process Industries
|
| O: 0.71%
H: 0.11%
C: -1.23%
covid covid-19
Sanofi and GSK Launch Late-Stage Trial for COVID-19 Vaccine Candidate
Published: 2021-05-27 (Crawled : 16:00) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.5%
H: 0.32%
C: -1.27%
covid vaccine trial covid-19
Will COVID-19 Vaccines Need a Booster? CDC Will Meet to Decide
Published: 2021-05-27 (Crawled : 15:00) - biospace.com/
JNJ | News | $148.53 -0.69% 0.11% 67K
|
Health Technology
|
| O: 0.11%
H: 0.54%
C: -0.27%
covid vaccine covid-19
Equifax Canada data indicates COVID-19 financial crisis is not over for consumers, small businesses
Published: 2021-05-27 (Crawled : 13:00) - globenewswire.com
EFX | $225.71 0.56% -0.06% 1
|
Commercial Services
|
| O: 0.66%
H: 0.38%
C: 0.32%
covid covid-19
Welsh Lighthouse Laboratory Extends Contract with PerkinElmer for its COVID-19 Solutions
Published: 2021-05-27 (Crawled : 10:00) - biospace.com/
PKI | $115.24 0.0% 1.6M
|
Health Technology
|
| O: -0.03%
H: 2.09%
C: 0.86%
covid contract covid-19
Sanofi and GSK initiate global Phase 3 clinical efficacy study of COVID-19 vaccine candidate
Published: 2021-05-27 (Crawled : 06:00) - globenewswire.com
JNJ | News | $148.53 -0.69% 0.11% 67K
|
Health Technology
|
| O: 0.11%
H: 0.54%
C: -0.27%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.5%
H: 0.32%
C: -1.27%
covid vaccine phase 3 covid-19
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M
|
BHIL | $0.1793 -4.37% 19.24% 340K
|
Agriculture, Forestry, Fishing ...
UMAC | $1.48 -1.33% 14.87% 20K
|
CI | $352.28 -0.11% 13.53% 2
|
Health Services
CIG.C | $2.89 -1.37% 12.8% 2.3K
|
n/a
MTH | $154.69 -2.21% 12.68% 450K
|
Consumer Durables
HCP | News | $31.41 7.75% 11.26% 1.2M
|
BMTX 4 | $1.545 0.98% 10.03% 2.5K
|
Information
TAL | $12.26 0.57% 9.22% 12M
|
Consumer Services
ASXC | $0.243 -2.41% 7.0% 1.1M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.